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Staphylococcus warneri, a Gram-positive human skin commensal bacterium, is catalase positive, oxidase negative, and coagulase negative. Like other coagulase-negative staphylococci, *S. warneri* rarely causes disease but may occasionally cause infection in immunocompromised patients ([@B1]). In this genome announcement, we report the draft genomes of two *S. warneri* strains, SMA0023-04 (UGA3) and SMA0670-05 (UGA28), isolated from the venous blood of pediatric patients at the Siaya County Referral Hospital (western Kenya) in 2004 and 2005, respectively. Isolate SMA0023-04 was from a febrile male pediatric patient 9.8 months of age who was HIV negative with Plasmodium falciparum malaria. Isolate SMA0670-05 was from a febrile female patient 7.93 months of age who was HIV negative with Plasmodium falciparum malaria.

Prior to any treatment interventions, blood was collected upon admission into a pediatric Isolator 1.5 microbial tube (Wampole Laboratories, Cranbury, NJ, USA) and cultivated at 35°C for 18 to 24 hours in 5% CO~2~ on 5% sheep blood agar. Bacterial DNA was extracted from a pure culture using the UltraClean microbial DNA isolation kit (Qiagen, Germantown, MD, USA) according to the manufacturer\'s instructions, with minimal modifications. The library was prepared from 100 ng of bacterial DNA by using an NEBNext Ultra DNA library prep kit for an Illumina instrument (New England Biolabs, Ipswich, MA, USA). *S. warneri* SMA0023-04 (UGA3) and SMA0670-05 (UGA28) were draft sequenced using a MiSeq version 2 500-cycle sequencing kit (Illumina, San Diego, CA, USA), generating 22,598,550 and 4,245,154 paired-end 251-bp reads resulting in 738- and 179-fold coverage, respectively. In addition, SMA0023-04 and SMA0670-05 contain at least one rep7-type and one rep20-type plasmid, respectively, findings which were supported by high coverage of *S. warneri* SG1 plasmids using BWA version 0.7.2 ([@B2]) read mapping from SMA0023-04 and SMA0670-05 as follows: 97.04% and 97.01% of *S. warneri* SG1 plasmid pvSw3, 58.79% and 59.98% of SG1 plasmid pvSw2, 56.17% and 67.57% of pvSw5, 38.84% and 26.79% of pvSw4, 37.66% and 26.17% of pvSw1, 25.40% and 43.69% of pSZ4, and 15.53% and 15.32% of pvSw6, respectively. Data quality was assessed and the data files were filtered and trimmed with FaQCs version 1.3 ([@B3]) and then assembled with Velvet version 1.2.08 ([@B4], [@B5]) and IDBA version 1.1.0 ([@B6]). The consensus sequences were computationally shredded and reassembled with Phrap version SPS-4.24 ([@B7], [@B8]) to allow some manual editing with Consed ([@B9]), resulting in 25 and 67 final contigs of \>200 bp (99.50% and 95.89% of the reads), with *N*~50~ values of 480,873 bp and 665,039 bp for SMA0023-04 and SMA0670-05, respectively. These contigs cover 89.26% and 91.77% of the *S. warneri* SG1 chromosome (GenBank accession number [NC_020164](https://www.ncbi.nlm.nih.gov/nuccore/NC_020164)), respectively ([@B10]), using Mummer alignment version 3.0 ([@B11]). The draft genomes of SMA0023-04 and SMA0670-05 consist of 2,466,813- and 2,555,257-bp sequences, with average G+C contents of 32.5% and 32.6%, respectively. Annotations were completed at LANL with an automated system using the Ergatis workflow manager version 2.0 ([@B12]) and in-house scripts.

In addition to 60 tRNA genes and 7 rRNA genes in the genome of each isolate, there are 2,492 and 2,552 predicted protein coding genes within the genomes of SMA0023-04 (UGA3) and SMA0670-05 (UGA28), respectively. Of these, 40% and 39% of the protein-coding genes were annotated in a SEED subsystem ([@B13]), whereas 60% and 61% were not annotated in a SEED subsystem, respectively; 682 and 782 genes were annotated as hypothetical proteins in SMA0023-04 and SMA0670-05, respectively. Of all the predicted genes, 2,247 are in common among SMA0023-04, SMA0670-05, and the *S. warneri* SG1 chromosome genomes, with 109, 168, and 111 genes being unique to SMA0023-04, SMA0670-05, and *S. warneri* SG1, respectively. Twenty-three, 22, and 17 genes are associated with resistance to antibiotics in SMA0023-04, SMA0670-05, and *S. warneri* SG1, respectively. Unlike other methicillin-susceptible coagulase-negative staphylococcus (CoNS) strains that are highly sensitive to various antimicrobial drugs ([@B14], [@B15]), SMA0023-04 has displayed resistance to tetracycline, macrolide, and ampicillin using the disk diffusion method ([@B16]). These observations are consistent with the presence of the tetracycline efflux major facilitator superfamily (MFS) transporter, PC1 beta-lactamase, ABC-efflux pump, and macrolide phosphotransferase encoded by *tetK*, *blaZ*, *msrC*, and *mphC* genes, respectively, on the SMA0023-04 (UGA3) plasmid.
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The GenBank accession numbers for Staphylococcus warneri SMA0023-04 (UGA3) and SMA0670-05 (UGA28) are [NWUB00000000](https://www.ncbi.nlm.nih.gov/nuccore/NWUB00000000) and [NWUA00000000](https://www.ncbi.nlm.nih.gov/nuccore/NWUA00000000), respectively. This BioProject ([PRJNA407975](https://www.ncbi.nlm.nih.gov/bioproject/PRJNA407975)) has been assigned BioSample numbers [SAMN07671984](https://www.ncbi.nlm.nih.gov/biosample/SAMN07671984) and [SAMN07671985](https://www.ncbi.nlm.nih.gov/biosample/SAMN07671985) and SRA accession numbers [SRR8655129](https://www.ncbi.nlm.nih.gov/sra/SRR8655129) and [SRR8655130](https://www.ncbi.nlm.nih.gov/sra/SRR8655130) for UGA3 and UGA28, respectively.

This work was supported by National Institutes of Health research grants R01AI51305, R01AI130473-01A1, and D43TW05884 (D.J.P.) and Los Alamos National Laboratory LDRD grant 20150090DR (B.M.).

LANL is operated by Los Alamos National Security, LLC, for the Department of Energy under contract DE-AC52-06NA25396.

[^1]: **Citation** Xie G, Cheng Q, Daligault H, Davenport K, Gleasner C, Jacobs L, Kubicek-Sutherland J, LeCuyer T, Otieno V, Raballah E, Doggett N, Mukundan H, Perkins DJ, McMahon B. 2019. Draft genome sequences of two *Staphylococcus warneri* clinical isolates, strains SMA0023-04 (UGA3) and SMA0670-05 (UGA28), from Siaya County Referral Hospital, Siaya, Kenya. Microbiol Resour Announc 8:e01595-18. <https://doi.org/10.1128/MRA.01595-18>.
